ES2058219T3 - Lineas celulares transfectadas que expresan el receptor principal del rinovirus humano. - Google Patents

Lineas celulares transfectadas que expresan el receptor principal del rinovirus humano.

Info

Publication number
ES2058219T3
ES2058219T3 ES88119774T ES88119774T ES2058219T3 ES 2058219 T3 ES2058219 T3 ES 2058219T3 ES 88119774 T ES88119774 T ES 88119774T ES 88119774 T ES88119774 T ES 88119774T ES 2058219 T3 ES2058219 T3 ES 2058219T3
Authority
ES
Spain
Prior art keywords
cell lines
human
receptor protein
express
human rhinovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88119774T
Other languages
English (en)
Inventor
Alan Mcclelland
Ann Marie Meyer
Jeffrey M Greve
Gary Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ES2058219T3 publication Critical patent/ES2058219T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Inert Electrodes (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LAS LINEAS DE CALCULOS DE MACUSFEROS NO FUMANOS QUE REPRESENTAN LA MAYOR PROTEINA RECEPTORA DE SINOVIRUS HUMANO. LAS LINEAS DE CALCULOS ESTAN PREPARADAS POR LA TRANSFECCION DE GUIAS DE DNA HUMANO, TAL COMO DNA DE ALULE HELA, EN CELULAS DE MAMIFEROS NO HUMANOS, TAL COMO CELULAS DE RATON. LOS TRANSFECTANTES PRIMARIOS PUEDEN SER TRANSFECTADO EN CELULAS ADICIONALES DE MAMIFEROS NO HUMANOS PARA PRODUCIR TRANSFECTANTES SECUNDARIOS. LA CLORIZACION DE LOS TRANSFECTANTES SECUNDARIOS PLRODUCEN LINEAS DE CELULAS QUE PRESENTAN UNA REPRESENTACION AUMENTADA DE LA PROTEINA RECEPTORA DE SINOVIRUS HUMANO E INMUNOGENES PARA PRODUCIR ANTICUERPOS, SU PARTICULAR ANTICUERPOS NONOCLONALES, CONTRA LA PROTEINA RECEPTORA. UN METODO GENERAL PARA CRIBAR CANDIDATOS DE DROGAS POR SU FACULTAD PARA BLOQUEAR EL ENLAZADOR DESLIGANTE A LA PROTEINA RECEPTORA SUPERFICIAL DE CELULAS HUMANAS ES TAMBIEN PROPORCIONADO.
ES88119774T 1987-12-08 1988-11-28 Lineas celulares transfectadas que expresan el receptor principal del rinovirus humano. Expired - Lifetime ES2058219T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13037887A 1987-12-08 1987-12-08
US26257088A 1988-10-25 1988-10-25

Publications (1)

Publication Number Publication Date
ES2058219T3 true ES2058219T3 (es) 1994-11-01

Family

ID=26828436

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88119774T Expired - Lifetime ES2058219T3 (es) 1987-12-08 1988-11-28 Lineas celulares transfectadas que expresan el receptor principal del rinovirus humano.

Country Status (7)

Country Link
EP (1) EP0319815B1 (es)
JP (1) JPH0242977A (es)
AT (1) ATE110771T1 (es)
AU (1) AU623105B2 (es)
CA (1) CA1341055C (es)
DE (1) DE3851309T2 (es)
ES (1) ES2058219T3 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831036A (en) * 1987-05-04 1998-11-03 Dana Farber Cancer Institute Soluble fragments of human intercellular adhesion molecule-1
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US7354588B1 (en) 1987-05-04 2008-04-08 Dana Farber Cancer Institute Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US6710169B2 (en) 1987-10-02 2004-03-23 Genentech, Inc. Adheson variants
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
ES2077572T3 (es) * 1988-09-28 1995-12-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular, y sus ligandos de fijacion.
NO900155L (no) * 1989-01-24 1990-07-25 Molecular Therapeutics Inc Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1.
CA2008368C (en) * 1989-01-24 2003-04-08 Jeffrey Greve Soluble molecule related to but distinct from icam-1
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
EP0387701B1 (en) * 1989-03-09 1992-08-12 Boehringer Ingelheim Pharmaceuticals Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
US6797270B1 (en) 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
US6777191B1 (en) 1989-03-16 2004-08-17 Center For Blood Research, Inc. Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection
DE69029528T2 (de) * 1989-03-16 1997-06-26 Blood Res Center Verwendung von funkionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
DE69131564T2 (de) * 1990-07-20 2000-01-13 Bayer Ag Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
US7241569B2 (en) 1993-01-18 2007-07-10 Olympus Corporation Method and a device for the evaluation of biopolymer fitness
WO1994016313A2 (de) * 1993-01-18 1994-07-21 Evotec Biosystems Gmbh Verfahren und vorrichtung zur bewertung der fitness von biopolymeren
CN113402601A (zh) * 2021-06-09 2021-09-17 河南中泽生物工程有限公司 一种抗非洲猪瘟病毒p54蛋白单克隆抗体的制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432170A1 (fr) * 1978-06-12 1980-02-22 Corning Glass Works Procede de mesure de recepteurs d'antigene sur des membranes de cellules
EP0169146A3 (en) * 1984-07-20 1988-07-20 Merck & Co. Inc. Monoclonal antibodies directed against the cellular receptor of human rhinovirus
EP0169729A3 (en) * 1984-07-23 1988-08-03 Becton Dickinson and Company Recovery of cell receptors
DE3712678A1 (de) * 1987-04-14 1988-10-27 Boehringer Ingelheim Int Rezeptor der kleinen rhinovirus rezeptor gruppe
US4893075A (en) * 1988-08-29 1990-01-09 Eaton Corporation Dual speed sensor pickup assembly with anti-cross talk coils

Also Published As

Publication number Publication date
AU623105B2 (en) 1992-05-07
AU2659488A (en) 1989-06-08
CA1341055C (en) 2000-07-18
EP0319815B1 (en) 1994-08-31
JPH0242977A (ja) 1990-02-13
EP0319815A2 (en) 1989-06-14
DE3851309T2 (de) 1994-12-22
EP0319815A3 (en) 1989-09-27
DE3851309D1 (de) 1994-10-06
ATE110771T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ES2058219T3 (es) Lineas celulares transfectadas que expresan el receptor principal del rinovirus humano.
Berridge et al. Spatial and temporal signalling by calcium
Szymczak et al. Correction of multi-gene deficiency in vivo using a single'self-cleaving'2A peptide–based retroviral vector
ES2096084T3 (es) Metodo para determinar la presencia de anticuerpos asociados con la diabetes o de anticuerpos dirigidos a celulas de los islotes.
ATE249476T1 (de) Cyclin d1 und seine cdna
DE59007589D1 (de) Verfahren zur Herstellung hetero-bispezifischer Antikörper.
Chou et al. Germline organization of the murine T cell receptor β-chain genes
Barton et al. Complete sequence and in vitro expression of a tissue-specific phosphatidylinositol-linked N-CAM isoform from skeletal muscle
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
ATE154636T1 (de) Dopamin-rezeptoren und gene
KR880007726A (ko) 안정하게 형질감염된 포유동물 세포에서 사람 에리트로포이에틴 유전자를 고농도 형질발현시키는 방법
Katz et al. The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.
ES2085247T1 (es) Receptores adrenergicos alfa 1 humanos que codifican dna y sus utilizaciones.
Couez et al. Each of the two productive T cell receptor α-gene rearrangements found in both the A10 and BM 3.3 T cell clones give rise to an α chain which can contribute to the constitution of a surface-expressed αβ dimer
Thyberg et al. Localization of platelet-derived growth factor (PDGF) in CHO cells transfected with PDGF A-or B-chain cDNA: retention of PDGF-BB in the endoplasmic reticulum and Golgi complex
Morelon et al. Endocytosis of the Common Cytokine Receptor γcChain: IDENTIFICATION OF SEQUENCES INVOLVED IN INTERNALIZATION AND DEGRADATION
Michaux et al. Clinical grade manufacture of CYAD-101, a NKG2D-based, first in class, non–gene-edited allogeneic CAR T-Cell therapy
Ben-Menahem et al. The biologic action of single-chain choriogonadotropin is not dependent on the individual disulfide bonds of the β subunit
Mesci et al. A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens
Obara et al. Fibroblast Contractility without an Increase in Basal Myosin Light Chain Phosphorylation in Wild Type Cells and Cells Expressing the Catalytic Domain of Myosin Light Chain Kinase (∗)
DE69124518D1 (de) Herstellung monoklonaler Antikörper gegen menschliches Vbeta T-Zellrezeptorelement unter Verwendung rekombinanter DNA-Vektoren
Altman et al. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines.
EP0346702A3 (en) Transfectant cell lines which express isolated genes of the carcinoembryonic antigen family
TW403783B (en) A gene encoding a polypeptide having pre-B cell growth-supporting ability
Rajasekar et al. Prolonged growth of activated B lymphocytes requires interaction with helper T cells

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 319815

Country of ref document: ES